Bloomberg, October 5, 2011 Teva Pharmaceutical Industries Ltd. (TEVA), the world’s biggest generic-drug maker, was accused by lawyers at a Nevada trial of putting profit ahead of the safety of colonoscopy patients who got the company’s Propofol anesthetic from reused vials. (Robert Eglet featured in article. Photo credit: Las Vegas Review-Journal)
News
Defense Witness in Second Hepatitis C Trial in Nevada, Dr. Arthur Reingold, Testimony on Plausible Cause for Contamination Impeached
PR Newswire , October 1, 2011 Dr. Arthur Reingold, witness for the defense in the second hepatitis C trial in Nevada, was called to the stand today offering expert testimony as an epidemiologist.
Eglet Law is Proud to Support the MDA (Muscular Dystrophy Association)
September 2, 2011 — Eglet Law is Proud to Support the MDA (Muscular Dystrophy Association). For the past 61 years, the MDA has helped millions of individuals who suffer from neuromuscular diseases. Through the annual MDA Labor Day Telethon and other local fundraising projects, the MDA is able to fund worldwide research, clinics, summer camps, education […]
Teva Faces Second Trial Over Hepatitis Cases Linked to Drug Propofol
Bloomberg, August 19, 2011 Teva Pharmaceutical Industries Ltd. (TEVA), the world’s biggest generic-drug maker, sold the anesthetic propofol in a way that led some patients to develop hepatitis C, a lawyer said at the start of a second trial over the allegations. (Robert Eglet featured in article.)
